FDA Can't Evade Prior Orphan Drug Ruling, Eagle Says
Eagle Pharmaceuticals Inc. urged a D.C. federal judge in oral arguments Friday to upend an FDA rejection of orphan drug exclusivity on a chemotherapy drug, arguing the agency is bound by...To view the full article, register now.
Already a subscriber? Click here to view full article